Rapid Dose Therapeutics Corp. (CSE: DOSE)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2024	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020
Market Capitalization	31	21	9	26	17	27
Market Cap Growth	33.23%	121.17%	-64.76%	56.16%	-36.29%	-57.36%
Enterprise Value	33	23	11	28	18	28
Last Close Price	0.24	0.17	0.09	0.26	0.21	0.34
PS Ratio	18.78	20.20	12.98	15.10	22.43	261.96
PB Ratio	-5.14	-6.53	-3.49	105.16	-15.55	-179.91
P/TBV Ratio	-	-	-	105.16	-	-
EV/Sales Ratio	24.87	23.00	15.75	15.81	24.39	273.86
Debt / Equity Ratio	-0.69	-0.78	-0.80	5.69	-2.01	-9.15
Asset Turnover	0.70	0.49	0.27	0.51	0.19	0.02
Inventory Turnover	2.56	2.79	1.66	1.26	0.43	0.37
Quick Ratio	0.10	0.13	0.04	0.09	0.08	0.03
Current Ratio	0.21	0.23	0.09	0.25	0.19	0.12
Return on Equity (ROE)	-	-	-	-	-	-432.88%
Return on Assets (ROA)	-130.88%	-93.10%	-83.34%	-77.93%	-25.16%	-93.14%
Return on Capital (ROIC)	-	-	-389.55%	-193.25%	-88.74%	-186.45%
Earnings Yield	-21.30%	-20.89%	-40.87%	-32.08%	-10.66%	-29.96%
FCF Yield	-14.14%	-11.13%	-9.27%	-11.49%	-9.64%	-16.01%
Buyback Yield / Dilution	7.40%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%
Total Shareholder Return	7.40%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%

Source: S&P Capital IQ. Standard template. Financial Sources.